Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 613,000 | 502,000 | 464,000 | 713,000 | 616,000 |
| Receivables | 947,000 | 959,000 | 858,000 | 770,000 | 951,000 |
| Inventories | 1,547,000 | 1,558,000 | 1,550,000 | 1,463,000 | 1,438,000 |
| Other current assets | 22,000 | 23,000 | 0 | 0 | 0 |
| TOTAL | $3,207,000 | $3,100,000 | $2,933,000 | $3,017,000 | $3,080,000 |
| Non-Current Assets | |||||
| PPE Net | 3,090,000 | 3,121,000 | 3,131,000 | 3,183,000 | 3,173,000 |
| Investments And Advances | 180,000 | 177,000 | 164,000 | 152,000 | 190,000 |
| Intangibles | 48,000 | 48,000 | 48,000 | 49,000 | 49,000 |
| Other Non-Current Assets | 1,045,000 | 1,042,000 | 1,118,000 | 1,112,000 | 971,000 |
| TOTAL | $4,363,000 | $4,388,000 | $4,461,000 | $4,496,000 | $4,383,000 |
| Total Assets | $7,570,000 | $7,488,000 | $7,394,000 | $7,513,000 | $7,463,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 52,000 | 38,000 | 43,000 | 54,000 | 53,000 |
| Accounts payable and accrued liabilities | 1,035,000 | 1,023,000 | 1,006,000 | 1,156,000 | 1,069,000 |
| Other current liabilities | 204,000 | 181,000 | 223,000 | 214,000 | 208,000 |
| TOTAL | $1,880,000 | $1,850,000 | $1,673,000 | $1,817,000 | $1,777,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,098,000 | 4,102,000 | 4,064,000 | 4,054,000 | 3,988,000 |
| Other Non-Current Liabilities | 1,274,000 | 1,273,000 | 1,049,000 | 1,019,000 | 998,000 |
| TOTAL | $5,390,000 | $5,399,000 | $5,141,000 | $5,108,000 | $5,027,000 |
| Total Liabilities | $7,270,000 | $7,249,000 | $6,814,000 | $6,925,000 | $6,804,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,892 | 149,698 | 149,674 | 149,441 | 149,411 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 1,312,000 | 1,265,000 | 1,659,000 | 1,701,000 | 1,763,000 |
| Other shareholders' equity | -282,000 | -291,000 | -337,000 | -366,000 | -351,000 |
| TOTAL | $300,000 | $239,000 | $580,000 | $588,000 | $659,000 |
| Total Liabilities And Equity | $7,570,000 | $7,488,000 | $7,394,000 | $7,513,000 | $7,463,000 |